GraniteShares 2x Long SpaceX Daily ETF

SPAL · ETF

$15.75+$0.545 (+3.58%)TodayMarket closed ·
Prev close $15.21

About SPAL

SPAL was created on 2026-06-15 by GraniteShares. The fund's investment portfolio concentrates primarily on communication services equity. SPAL provides 2x leveraged exposure, less fees and expenses, to the daily price movement for shares of Space Exploration Technologies Corp, (NASDAQ: SPCX) stock.

Issuer
GraniteShares
Expense ratio
1.5%
Assets under management
$42.01M
Inception
Jun 15, 2026
Asset class
Equity

SPAL key statistics

Price-earnings ratio
0.00
Average volume
1.11M
Volume
718.12K
Open price
$15.87
High today
$16.20
Low today
$15.06
52 Week high
$46.57
52 Week low
$8.91

GraniteShares 2x Long SpaceX Daily ETF (SPAL) at a glance

As of Oct 23, 2026, GraniteShares 2x Long SpaceX Daily ETF (SPAL) shares are priced at $15.75, giving the company a price-to-earnings ratio of 0.00.

Today the fund has traded between $15.06 and $16.20. The current price is 4.6% above the day's low and 2.8% below its high.

Volume so far is 718.12K shares, below the average of 1.11M shares a day.

Over the past year GraniteShares 2x Long SpaceX Daily ETF has ranged from $8.91 to $46.57, and now sits 18% of the way up that range.

SPAL news

  • Chandrima Sanyal

    SpaceX Lit the Fuse. These 5 ETFs Are Already Blasting Off

  • Chandrima Sanyal

    Gina Rinehart Makes SpaceX Her Biggest U.S. Bet—ETFs Offer Investors Another Route In

  • Chandrima Sanyal

    SpaceX ETF Frenzy Reaches 'Bonkers' Levels As Volume Surges Past $1 Billion

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.